Cargando…

Evaluation of a New Topical Treatment for the Control of Cutaneous Leishmaniasis

Leishmania major (L. major) causes cutaneous leishmaniasis in the Old World. The infection mostly induces a localized lesion restricted to the sand fly bite. The costs and the side effects of current treatments render imperative the development of new therapies that are affordable and easy to admini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Salazar, Berenice, Carregaro Pereira, Vanessa, Hauyon-La-Torre, Yazmin, Khamesipour, Ali, Tacchini-Cottier, Fabienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696824/ https://www.ncbi.nlm.nih.gov/pubmed/33212818 http://dx.doi.org/10.3390/microorganisms8111803

Ejemplares similares

Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis
por: Govender, Melissa, et al.
Publicado: (2018)

The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis
por: Passelli, Katiuska, et al.
Publicado: (2022)

Repeated Exposure to Lutzomyia intermedia Sand Fly Saliva Induces Local Expression of Interferon-Inducible Genes Both at the Site of Injection in Mice and in Human Blood
por: Weinkopff, Tiffany, et al.
Publicado: (2014)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Local Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in Ethiopia
por: Abebe, Tamrat, et al.
Publicado: (2012)

Topical paromomycin for New World cutaneous leishmaniasis
por: Sosa, Néstor, et al.
Publicado: (2019)

Cutaneous Leishmaniasis Situation and Predicting the Distribution of Phlebotomus papatasi and P. sergenti as Vectors of Leishmaniasis in Ardabil Province, Iran
por: Khamesipour, Ali, et al.
Publicado: (2020)

Topical Paromomycin and Gentamicin for New World Cutaneous Leishmaniasis in Panama
por: Monge-Maillo, Begoña, et al.
Publicado: (2014)

Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions
por: Regli, Ivo B., et al.
Publicado: (2018)

Identification of etiologic agents of cutaneous Leishmaniasis in palpebral position followed by effective therapy
por: Saberi, Sedigheh, et al.
Publicado: (2017)

IL-4Rα Signaling in Keratinocytes and Early IL-4 Production Are Dispensable for Generating a Curative T Helper 1 Response in Leishmania major-Infected C57BL/6 Mice
por: Descatoire, Marc, et al.
Publicado: (2017)

Effect of topical berberine in murine cutaneous leishmaniasis lesions
por: Calvo, Alba, et al.
Publicado: (2022)

Evaluation of Skin Permeation and Retention of Topical Dapsone in Murine Cutaneous Leishmaniasis Lesions
por: Moreno, Esther, et al.
Publicado: (2019)

Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: In -vivo analysis
por: Sharma, Harshita, et al.
Publicado: (2023)

Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (ALM) and Quillaja Saponins
por: Tafaghodi, Mohsen, et al.
Publicado: (2016)

Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2020)

Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
por: Takele, Yegnasew, et al.
Publicado: (2013)

Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites
por: Hadighi, Ramtin, et al.
Publicado: (2006)

Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model
por: Tacchini-Cottier, Fabienne, et al.
Publicado: (2012)

The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection
por: Passelli, Katiuska, et al.
Publicado: (2021)

The role of ATP-binding cassette transporter genes expression in treatment failure cutaneous leishmaniasis
por: Boozhmehrani, Mohammad Javad, et al.
Publicado: (2022)

CD8(+) T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis
por: Nateghi Rostami, Mahmoud, et al.
Publicado: (2010)

Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
por: Takele, Yegnasew, et al.
Publicado: (2013)

Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review
por: Azim, Marium, et al.
Publicado: (2021)

Old World Cutaneous Leishmaniasis: Successful response to topical imiquimod
por: Llamas-Molina, Jose M., et al.
Publicado: (2022)

Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report
por: MORTAZAVI, Hossein, et al.
Publicado: (2015)

Cutaneous Leishmaniasis in Bam: A Comparative Evaluation of Pre- and Post-Earthquake Years (1999–2008)
por: Sharifi, I, et al.
Publicado: (2011)

Effect of Topical Morphine on Cutaneous Leishmaniasis in an Animal Model: A Preliminary Report
por: Ghaffarpasand, Fariborz, et al.
Publicado: (2016)

Comparison of cytokine profile of IFN-γ, IL-5 and IL-10 in cutaneous leishmaniasis using PBMC vs. whole blood
por: Mohammadi, Akram Miramin, et al.
Publicado: (2019)

Topical Bambusa vulgaris Extract Enhances Wound Healing in Cutaneous Leishmaniasis
por: Ghanbarinasab, Zahra, et al.
Publicado: (2021)

The efficacy of hydro alcoholic extract of Seidlitzia rosmarinus on experimental zoonotic cutaneous leishmaniasis lesions in murine model
por: Ahmadi, Maryam, et al.
Publicado: (2014)

Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2014)

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis
por: Nilforoushzadeh, Mohammad Ali, et al.
Publicado: (2007)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

A Prospective Cohort Study of Cutaneous Leishmaniasis Risk and Opium Addiction in South Eastern Iran
por: Aflatoonian, Mohammad Reza, et al.
Publicado: (2014)

Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial
por: Khatami, Alireza, et al.
Publicado: (2013)

The Prominent Role of Neutrophils during the Initial Phase of Infection by Leishmania Parasites
por: Charmoy, Mélanie, et al.
Publicado: (2010)

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2018)

Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin G., et al.
Publicado: (2012)

Potential biomarkers of immune protection in human leishmaniasis
por: Rostami, Mahmoud Nateghi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s7fcpfq0vgblk0cr82fm8be4n1